FIELD: biotechnologies.
SUBSTANCE: invention refers to a compound having general formula 
(I),
where: m and n are independent integer numbers of 1 to 6; each of X1-X3 and Y1-Y3 is O; each of R1-R3 is independently chosen from a group consisting of hydrogen or alkyl; and R is O-(CH2)x-C(-O)NR'-(CH2)y-NHR'. Besides, x and y are independent integer numbers of 1 to 6; and R' is chosen from the group consisting of hydrogen and alkyl. In addition, an antibody containing an antigen recognition area, use of the compound, pharmaceutical composition, use of the antibody, method for MMP-2 or MMP-9 activity inhibition in a sample and a composition for determining MMP-2 or MMP-9 are proposed.
EFFECT: invention allows obtaining compounds that are able to inhibit MMP-2 or MMP-9 activity.
11 cl, 16 dwg, 4 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF FUSED TIMP-GPI CONSTRUCT AND METHOD OF TREATING SKIN INJURES FOR CICATRISATION PREVENTION OR INHIBITION | 2006 |
|
RU2428479C2 |
| METHOD FOR INHIBITION OF ANGIOGENESIS AND TUMOR GROWTH | 2001 |
|
RU2269339C2 |
| ANTIBODY DRUG CONJUGATES | 2014 |
|
RU2669812C2 |
| ANTIBODIES BINDING TO LYSYL OXIDASE-LIKE ENZYME-2 (LOXL2), AND METHOD FOR PREPARING THEM | 2011 |
|
RU2549684C2 |
| OPIORPHIN PEPTIDE DERIVATIVES AS POTENTIAL INHIBITORS OF ECTOPEPTIDASES, PARTICIPATING IN DEGRADATION OF ENKEPHALINS | 2009 |
|
RU2542365C2 |
| METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF DISEASES ASSOCIATED WITH TUBULIN CARBOXYPEPTIDASES (TCP) | 2018 |
|
RU2812207C2 |
| METHODS AND COMPOSITIONS FOR TREATMENT OF PULMONARY FIBROUS DISEASES | 2010 |
|
RU2561672C2 |
| METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH TUBULIN CARBOXYPEPTIDASES (TCP) | 2018 |
|
RU2797200C1 |
| ANTIBODIES AGAINST TENB2 CONSTRUCTED WITH CYSTEINE, AND CONJUGATES, ANTIBODY-DRUG | 2008 |
|
RU2505544C2 |
| PRODRUG CONTAINING SELF-CLEAVABLE LINKER | 2014 |
|
RU2676324C2 |
